Search research articles
Contact Us
Filters
Showing results (71-80 of 93) with videos related to
Page
of 10
Sort By:
Angewandte Chemie (International Ed. in English)
|
July 8, 2025
Rational Design of CDK12/13 and BRD4 Molecular Glue Degraders
Zhe Zhuang, Woong Sub Byun, Zuzanna Kozicka, et al.
Journal of the American Chemical Society
|
November 27, 2025
Rewiring the Fusion Oncoprotein EWSR1::FLI1 in Ewing Sarcoma with Bivalent Small Molecules
Michael J Bond, Ryan P Golden, Giulia DiGiovanni, et al.
Clinical Pharmacokinetics
|
February 20, 2016
Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels
Hannah M Jones, Richard P Butt, Rob W Webster, et al.
Diabetes Technology & Therapeutics
|
January 9, 2019
Glucose Control Using a Standard Versus an Enhanced Hybrid Closed Loop System: A Randomized Crossover Study
Barbora Paldus, Melissa H Lee, Hannah M Jones, et al.
Diabetes Technology & Therapeutics
|
July 3, 2019
Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study
Melissa H Lee, Sara Vogrin, Barbora Paldus, et al.
Diabetes Care
|
December 5, 2019
Glucose and Counterregulatory Responses to Exercise in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia Using Closed-Loop Insulin Delivery: A Randomized Crossover Study
Melissa H Lee, Sara Vogrin, Barbora Paldus, et al.
Journal of Medicinal Chemistry
|
January 28, 2025
Development of Potent and Selective CK1α Molecular Glue Degraders
Qixiang Geng, Zixuan Jiang, Woong Sub Byun, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
Discovery of electrophilic degraders that exploit S<sub>N</sub>Ar chemistry
Zhe Zhuang, Woong Sub Byun, Zuzanna Kozicka, et al.
Mabs
|
May 28, 2016
Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodies
Lindsay B Avery, Mengmeng Wang, Mania S Kavosi, et al.
Diabetes Care
|
August 7, 2021
Fast-Acting Insulin Aspart Versus Insulin Aspart Using a Second-Generation Hybrid Closed-Loop System in Adults With Type 1 Diabetes: A Randomized, Open-Label, Crossover Trial
Melissa H Lee, Barbora Paldus, Sara Vogrin, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 93) with videos related to
Sort By:
Page
of 10
Angewandte Chemie (International Ed. in English)
|
July 8, 2025
Rational Design of CDK12/13 and BRD4 Molecular Glue Degraders
Zhe Zhuang, Woong Sub Byun, Zuzanna Kozicka, et al.
Journal of the American Chemical Society
|
November 27, 2025
Rewiring the Fusion Oncoprotein EWSR1::FLI1 in Ewing Sarcoma with Bivalent Small Molecules
Michael J Bond, Ryan P Golden, Giulia DiGiovanni, et al.
Clinical Pharmacokinetics
|
February 20, 2016
Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels
Hannah M Jones, Richard P Butt, Rob W Webster, et al.
Diabetes Technology & Therapeutics
|
January 9, 2019
Glucose Control Using a Standard Versus an Enhanced Hybrid Closed Loop System: A Randomized Crossover Study
Barbora Paldus, Melissa H Lee, Hannah M Jones, et al.
Diabetes Technology & Therapeutics
|
July 3, 2019
Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study
Melissa H Lee, Sara Vogrin, Barbora Paldus, et al.
Diabetes Care
|
December 5, 2019
Glucose and Counterregulatory Responses to Exercise in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia Using Closed-Loop Insulin Delivery: A Randomized Crossover Study
Melissa H Lee, Sara Vogrin, Barbora Paldus, et al.
Journal of Medicinal Chemistry
|
January 28, 2025
Development of Potent and Selective CK1α Molecular Glue Degraders
Qixiang Geng, Zixuan Jiang, Woong Sub Byun, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
Discovery of electrophilic degraders that exploit S<sub>N</sub>Ar chemistry
Zhe Zhuang, Woong Sub Byun, Zuzanna Kozicka, et al.
Mabs
|
May 28, 2016
Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodies
Lindsay B Avery, Mengmeng Wang, Mania S Kavosi, et al.
Diabetes Care
|
August 7, 2021
Fast-Acting Insulin Aspart Versus Insulin Aspart Using a Second-Generation Hybrid Closed-Loop System in Adults With Type 1 Diabetes: A Randomized, Open-Label, Crossover Trial
Melissa H Lee, Barbora Paldus, Sara Vogrin, et al.
Page
of 10